Application of medicinal composition in manufacturing of medical apparatus and instruments

Abstract

The invention relates to an application of a medicinal composition of vasoactive medicinal materials including alprostadil, papaverine and phentolamine in medical apparatus and instruments. The invention further provides a male condom with time delaying and erection promoting effects. The novel application of the medicinal composition of alprostadil, papaverine and phentolamine is provided, in addition, the inner wall of a male condom body is taken as a backing body, and an auxiliary component, namely, a penetration enhancer is adopted, thus the medicine is administrated through a skin penetration way, further, the complications caused by the medicine injection is reduced, the use is convenient, and the time delaying and erection promoting purposes are achieved; the medicinal composition has short-term and long-term treatment effects for the erectile dysfunction, and is beneficial for the medication persistence of the patient, therefore, the treatment effects are improved, the applications are wide, and the popularization is easy.

Description

technical field [0001] The present invention relates to the application of the combination of vasoactive drugs alprostadil, papaverine and phentolamine according to the mass ratio of 60 to 70:50:1, specifically the application of the drug combination in the preparation of medical equipment, and an extended Time-boosting condoms and their applications. Background technique [0002] Erectile dysfunction is a common sexual dysfunction, and the current treatment method is to take PDE-5 inhibitors on demand or in small doses for a long time as the main means. According to the latest literature reports and our clinical experience, intracavernosal injection of vasoactive drugs alprostadil, papaverine, and phentolamine in a mass ratio of 60-70:50:1 can effectively improve the erectile function of patients. And improve the symptoms of premature ejaculation to a certain extent. However, the intracavernosal injection of vasoactive drugs such as alprostadil has limited clinical applic...

AI Technical Summary

Problems solved by technology

However, the intracavernosal injection of vasoactive drugs such as alprostadil has limited clinical application due to its invasiveness, short-term complications of priapism and long-term complications of penile cavernous body fibrosis, and is not easily accepted by patients. Therefore, how to avoid the complications caused by the use of such drugs and achieve a better therapeutic effect will be an important breakthrough in the use of such drugs

Images